Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)

Market Cap	2.34B +46.8%
Revenue (ttm)	203.85M -15.7%
Net Income	16.34M -45.6%
EPS	0.13 -45.6%
Shares Out	121.78M
PE Ratio	143.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,365,702
Open	19.45
Previous Close	19.29
Day's Range	18.88 - 19.59
52-Week Range	13.21 - 23.44
Beta	0.00
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:600671

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces tablets, granules, pills, oral solutions, and other medications; and health food products, including oral liquids, syrups, eye drops, pills, soft capsules, tablets, and granules. It also sells prepared slices of traditional Chinese medicine. In addition, the company operates Chinese medicine clinic; provision of traditional chinese medicine clinic, soft...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1958
• Employees: 392
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600671

Financial Performance

In 2025, SHA:600671's revenue was 211.75 million, a decrease of -2.55% compared to the previous year's 217.30 million. Earnings were 17.62 million, an increase of 15.59%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error